First Personal Financial Services’s Syndax Pharmaceuticals SNDX Stock Holding History

First Personal Financial Services’s Portfolio SNDX Stock Details SNDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-772	Closed	-$11K	–	894
2018 Q1	$11K	Sell	772 -520	-40%	-$5.52K	﹤0.01%	769
2017 Q4	$11K	Buy	1,292 +117	+10%	+$1.16K	﹤0.01%	770
2017 Q3	$14K	Hold	1,175	–	–	﹤0.01%	650
2017 Q2	$16K	Buy	1,175 +106	+10%	+$1.21K	﹤0.01%	622
2017 Q1	$15K	Hold	1,069	–	–	﹤0.01%	624
2016 Q4	$8K	Buy	+1,069	New	+$11.7K	﹤0.01%	763

Other funds holding SNDX

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

MAM

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

First Personal Financial Services's SNDX Position: Q2 2018 in Review

First Personal Financial Services sold out of Syndax Pharmaceuticals (SNDX) in Q2 2018, closing a stake of 772 shares — an estimated $11K sold.

First Personal Financial Services first reported a position in SNDX in Q4 2016 and held it in 6 quarters. The position peaked at $16K in Q2 2017. 84 funds tracked by Wall St. Rank hold SNDX as of Q2 2018.

First Personal Financial Services reported no remaining Syndax Pharmaceuticals position as of Q2 2018 after selling out during the quarter.
First Personal Financial Services sold 772 Syndax Pharmaceuticals shares in Q2 2018, an estimated $11K.
First Personal Financial Services first reported a position in Syndax Pharmaceuticals in Q4 2016 and held it in 6 quarters.
First Personal Financial Services's Syndax Pharmaceuticals position peaked at $16K in Q2 2017.
84 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q2 2018.

Based on First Personal Financial Services's 13F filing for Q2 2018, filed 7 Aug 2018.